{"url_path":"/sec/aspn/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1145986/0001193125-26-214672-index.html","accession_number":"0001193125-26-214672","cik":"0001145986","ticker":"ASPN","issuer_name":"ASPEN AEROGELS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1145986/0001193125-26-214672-index.html","primary_entity_key":"0001145986","primary_entity_name":"ASPEN AEROGELS INC"},"word_count":71,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(c) 10b5-1 Trading Plans\n\nNone of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement” as such term is defined in Item 408(a) of Regulation S-K, during the fiscal quarter ended March 31, 2026.\n\n38"}